论文部分内容阅读
目的:探究孟鲁司特钠治疗小儿咳嗽变异性哮喘的临床疗效。方法:选择2015年1月-2015年6月来我院就诊的62例咳嗽变异性哮喘小儿患者为研究对象,将其分成两组,对照组使用常规方式治疗,以此为基础,观察组使用孟鲁司特钠进行治疗,对比两组患者的临床疗效,不良反应时间,复发情况和临床症状缓解时间。结果:对照组患者临床有效率为80.65%。观察组为93.55%。从复发率,临床症状缓解时间上来看,观察组患者明显好于对照组,组间数据存在统计学意义,治疗期间观察注患者有2例出现了不良症状,因症状不影响治疗,故未进行特别处理。结论:对于小儿变异性咳嗽哮喘患者,以常规方式为基础,使用孟鲁司特钠进行治疗,可以取得相对满意的临床效果,且不良反应少,值得进一步在临床治疗中推广。
Objective: To investigate the clinical efficacy of montelukast sodium in the treatment of children with cough variant asthma. Methods: Sixty-two children with cough variant asthma treated in our hospital from January 2015 to June 2015 were selected as study subjects and divided into two groups. The control group was treated by conventional methods. Based on this, the observation group was used Montelukast sodium treatment, the two groups of patients compared the clinical efficacy, adverse reaction time, recurrence and clinical symptoms of remission time. Results: The clinical effective rate of the control group was 80.65%. The observation group was 93.55%. From the recurrence rate and clinical symptom relief time point of view, the observation group was significantly better than the control group, the data between the groups was statistically significant during treatment observed in patients with injection of 2 cases of adverse symptoms, because the symptoms do not affect the treatment, it is not carried out Special treatment. Conclusion: In children with variant cough and asthma, the treatment with montelukast sodium based on the conventional method can achieve a relatively satisfactory clinical effect with less adverse reactions and is worth further promotion in clinical treatment.